Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WASEEMULLAH KHAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1073557864
CMS profile
48213
Location
LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,584.15

143 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,568.45 142
Education $15.70 1

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $173.90 10
Merck Sharp & Dohme Corporation $169.21 9
E.R. Squibb & Sons, L.L.C. $130.20 7
Seagen Inc. $129.32 9
Janssen Biotech, Inc. $121.14 7
Daiichi Sankyo Inc. $120.54 6
Exelixis Inc. $117.40 6
Amgen Inc. $110.71 6
Biogen, Inc. $98.74 1
Celgene Corporation $91.18 5
PFIZER INC. $80.48 7
Astellas Pharma US Inc $79.91 5
Bayer HealthCare Pharmaceuticals Inc. $79.02 4
Foundation Medicine, Inc. $74.94 1
Lilly USA, LLC $72.80 5
Octapharma USA, Inc. $70.09 1
Pharmacyclics LLC, An AbbVie Company $69.86 4
EMD Serono, Inc. $66.10 3
Taiho Oncology, Inc. $64.35 4
Novartis Pharmaceuticals Corporation $63.82 4
Incyte Corporation $63.67 5
Eisai Inc. $53.02 3
AbbVie Inc. $45.04 2
Ipsen Biopharmaceuticals, Inc $38.30 2
Blue Earth Diagnostics Limited $36.19 2
GENZYME CORPORATION $33.28 2
ARRAY BIOPHARMA INC $33.15 3
Servier Pharmaceuticals LLC $30.39 2
Regeneron Healthcare Solutions, Inc. $26.13 2
Global Blood Therapeutics, Inc. $24.60 2
Agios Pharmaceuticals, Inc. $21.40 1
Boehringer Ingelheim Pharmaceuticals, Inc. $18.79 1
EUSA Pharma (US) LLC $18.57 1
Dova Pharmaceuticals $18.44 1
Takeda Pharmaceuticals U.S.A., Inc. $17.49 1
Genentech USA, Inc. $14.95 1
Alexion Pharmaceuticals, Inc. $14.75 1
Kite Pharma, Inc. $14.45 1
PUMA BIOTECHNOLOGY, INC. $14.14 1
Myriad Genetic Laboratories, Inc. $13.84 1
Blueprint Medicines Corporation $13.20 1
SUN PHARMACEUTICAL INDUSTRIES INC. $13.05 1
BeiGene USA, Inc. $11.96 1
Kyowa Kirin, Inc. $11.64 1

Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WASEEMULLAH KHAN

NPI 1073557864 · CMS profile ID 48213

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073557864?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073557864?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073557864?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1073557864?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

143 matching records · $2,584.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 143 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 143.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Exelixis Inc. $48.7108/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838871031 CMS
Seagen Inc. $14.3308/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832138649 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.4908/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820016645 CMS
Amgen Inc. $14.4708/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826454031 CMS
Lilly USA, LLC $16.1908/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818779125 CMS
Incyte Corporation $13.4508/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835544297 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.6107/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789048741 CMS
PFIZER INC. $13.6607/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832613383 CMS
GENZYME CORPORATION $20.0707/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843509767 CMS
Novartis Pharmaceuticals Corporation $17.1007/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812749105 CMS
ARRAY BIOPHARMA INC $10.7207/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833164753 CMS
E.R. Squibb & Sons, L.L.C. $22.0007/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783579685 CMS
Blue Earth Diagnostics Limited $18.0407/09/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 844633473 CMS
EUSA Pharma (US) LLC $18.5707/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852885267 CMS
Pharmacyclics LLC, An AbbVie Company $22.8407/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781011833 CMS
AstraZeneca Pharmaceuticals LP $19.3707/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830023239 CMS
Kyowa Kirin, Inc. $11.6407/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852987385 CMS
Incyte Corporation $12.2506/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835544271 CMS
AstraZeneca Pharmaceuticals LP $20.1106/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829985155 CMS
Daiichi Sankyo Inc. $23.3206/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836301127 CMS
Merck Sharp & Dohme Corporation $19.4606/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848543991 CMS
Celgene Corporation $14.9706/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783712297 CMS
Taiho Oncology, Inc. $15.4006/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843379561 CMS
AbbVie Inc. $31.7106/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795085893 CMS
Exelixis Inc. $15.7506/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838869867 CMS
Octapharma USA, Inc. $70.0906/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812974717 CMS
Seagen Inc. $15.9606/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832138631 CMS
Exelixis Inc. $12.6206/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838869645 CMS
PFIZER INC. $9.1306/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833286109 CMS
Astellas Pharma US Inc $18.3306/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821396797 CMS
PFIZER INC. $11.7705/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832700615 CMS
Genentech USA, Inc. $14.9505/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835989825 CMS
Biogen, Inc. $98.7405/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794673 CMS
Daiichi Sankyo Inc. $15.3605/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836288387 CMS
Lilly USA, LLC $11.0705/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818823503 CMS
Merck Sharp & Dohme Corporation $21.0805/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848330587 CMS
Janssen Biotech, Inc. $25.1705/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788997129 CMS
PFIZER INC. $11.4305/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833242287 CMS
PUMA BIOTECHNOLOGY, INC. $14.1405/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834092733 CMS
GENZYME CORPORATION $13.2105/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843509713 CMS
E.R. Squibb & Sons, L.L.C. $18.7005/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783579663 CMS
ARRAY BIOPHARMA INC $9.6205/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833163615 CMS
Regeneron Healthcare Solutions, Inc. $11.3105/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809593085 CMS
AstraZeneca Pharmaceuticals LP $20.4105/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829927219 CMS
AstraZeneca Pharmaceuticals LP $19.3705/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829544187 CMS
Seagen Inc. $10.2804/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832138609 CMS
Janssen Biotech, Inc. $14.9704/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788997131 CMS
Incyte Corporation $12.2504/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835544261 CMS
AstraZeneca Pharmaceuticals LP $17.6304/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829449469 CMS
Merck Sharp & Dohme Corporation $20.4904/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848620903 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,883.25 152
PY2020 $1,895.57 113
PY2021 $2,584.15 143
PY2022 $4,558.44 158
PY2023 $3,338.16 162
PY2024 $4,152.90 157
PY2025 $2,690.05 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,344.76 4
PY2023 Principal investigator $9,423.25 2
PY2022 Principal investigator $350.00 1
PY2021 Principal investigator $831.25 2
PY2020 Principal investigator $14,993.25 3
PY2019 Principal investigator $23,071.51 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sumitomo Pharma America, Inc. $637.88 04/17/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431052
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $137.50 03/07/2024 Non-covered Recipient Entity
Lake City Cancer Care Llc
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice No dispute reported 06/30/2026 1155196573
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431048
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431050